Total population (n = 98) | |||||
Median serum IL6, pg/ml (min-max) | 1.09 (0.30–3.76) | ||||
By C. acnes category | C. acnes + (n = 60) | C. acnes- (n = 38) | |||
Median serum IL6, pg/ml (min-max) | 1.04 (0.35–3.76) | 1.16 (0.30–3.13) | p = 0.106a | ||
Gleason sum | Gleason 6 (n = 36) | Gleason 3 + 4 (n = 42) | Gleason 4 + 3 (n = 16) | Gleason 8+ (n = 4) | |
Median serum IL6, pg/ml (min-max) | 1.02 (0.3–3.76) | 1.09 (0.45–3.13) | 1.14 (0.47–2.05) | 1.12 (0.7–1.37) | p = 0.836a |
Positive sugical margins | No (n = 64) | Yes (n = 34) | |||
Median serum IL6, pg/ml (min-max) | 1.12 (0.3–3.76) | 1.03 (0.39–2.97) | p = 0.420a | ||
pT stage | pT2 (n = 87) | pT3 (n = 11) | |||
Median serum IL6, pg/ml (min-max) | 1.1 (0.3–3.76) | 1.05 (0.61–2.06) | p = 0.862a | ||
PSA | |||||
By PSA quartile | < 4.6 ng/ml | ≥4.6, < 6.4 ng/ml | ≥6.4, < 9.0 ng/ml | ≥9 ng/ml | |
Median serum IL6, pg/ml (min-max) | 1.02 (0.45–2.88) | 1.08 (0.47–2.23) | 1.12 (0.3–3.13) | 1.16 (0.39–3.76) | p = 0.601a |
Non-parametric correlation | |||||
Correlation coefficient | 0.058 | p = 0.571b | |||
Age | |||||
By age quartile | < 61.3 years | ≥61.3, < 64.7 years | ≥64.7, < 67.1 years | ≥67.1 years | |
Median serum IL6, pg/ml (min-max) | 1.09 (0.3–3.13) | 0.93 (0.39–2.97) | 1.17 (0.47–3.76) | 1.11 (0.35–2.88) | p = 0.416a |
Non-parametric correlation | |||||
Correlation coefficient | 0.113 | p = 0.270b | |||
Prostate volume | |||||
By volume quartile | 10–26 ml | 27–33 ml | 34–50 ml | 51–138 ml | |
Median serum IL6, pg/ml (min-max) | 1.39 (0.3–3.76) | 1.1 (0.56–2.68) | 1.06 (0.39–2.73) | 1.1 (0.35–2.78) | p = 0.397a |
Non-parametric correlation | |||||
Correlation coefficient | −0.106 | p = 0.321b |